Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2020

Shelley Wood

December 31, 2020

News Daily News

As ED Visits Declined Amid COVID-19 in England, CV Deaths Ticked Up

Shelley Wood

December 23, 2020

News Daily News

Fracking, Other Natural Gas Activity Linked to Hospitalizations for HF Patients

L.A. McKeown

December 07, 2020

News Daily News

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

Shelley Wood

September 18, 2020

News Conference News ESC 2020

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

Todd Neale

August 30, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

Too Many HF Trial Results Underreported or Never Published

L.A. McKeown

June 23, 2020

News Daily News

VA Efforts to Cut HF Readmissions are Working, With No Uptick in Deaths

L.A. McKeown

June 18, 2020

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

News Daily News

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

Shelley Wood

May 14, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Todd Neale

March 17, 2020

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2020

As ED Visits Declined Amid COVID-19 in England, CV Deaths Ticked Up

Fracking, Other Natural Gas Activity Linked to Hospitalizations for HF Patients

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Too Many HF Trial Results Underreported or Never Published

VA Efforts to Cut HF Readmissions are Working, With No Uptick in Deaths

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content